LWAM
LMAT icon

Legacy Wealth Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Legacy Wealth Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,769
Closed -$848K – 396
2026
Q1 		$848K Buy
7,769
+23
+0.3% +$2.19K 0.21% 151
2025
Q4 		$628K Sell
7,746
-134
-2% -$11.5K 0.15% 218
2025
Q3 		$690K Sell
7,880
-147
-2% -$13.1K 0.17% 197
2025
Q2 		$667K Buy
8,027
+4
+0% +$334 0.17% 186
2025
Q1 		$673K Sell
8,023
-89
-1% -$8.28K 0.19% 170
2024
Q4 		$747K Sell
8,112
-791
-9% -$76.1K 0.2% 141
2024
Q3 		$827K Sell
8,903
-68
-0.8% -$5.89K 0.22% 121
2024
Q2 		$738K Buy
8,971
+69
+0.8% +$5.07K 0.21% 132
2024
Q1 		$591K Buy
8,902
+5
+0.1% +$309 0.16% 199
2023
Q4 		$505K Buy
8,897
+38
+0.4% +$1.99K 0.17% 222
2023
Q3 		$483K Sell
8,859
-1,727
-16% -$102K 0.18% 205
2023
Q2 		$712K Sell
10,586
-2,727
-20% -$166K 0.25% 124
2023
Q1 		$685K Sell
13,313
-5,082
-28% -$247K 0.25% 135
2022
Q4 		$847K Buy
18,395
+340
+2% +$15.9K 0.32% 98
2022
Q3 		$915K Sell
18,055
-333
-2% -$16.6K 0.4% 76
2022
Q2 		$838K Buy
18,388
+811
+5% +$36.3K 0.34% 112
2022
Q1 		$817K Buy
17,577
+821
+5% +$36.7K 0.29% 139
2021
Q4 		$842K Buy
16,756
+2,487
+17% +$129K 0.29% 143
2021
Q3 		$758K Buy
14,269
+85
+0.6% +$4.79K 0.35% 118
2021
Q2 		$866K Sell
14,184
-822
-5% -$43.7K 0.38% 96
2021
Q1 		$732K Buy
15,006
+1,000
+7% +$46.9K 0.34% 119
2020
Q4 		$567K Buy
+14,006
New +$501K 0.29% 144

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Legacy Wealth Asset Management's LMAT Position: Q2 2026 in Review

Legacy Wealth Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 7,769 shares — an estimated $848K sold.

Legacy Wealth Asset Management first reported a position in LMAT in Q4 2020 and held it in 22 quarters. The position peaked at $915K in Q3 2022. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Legacy Wealth Asset Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 7,769 LeMaitre Vascular shares in Q2 2026, an estimated $848K.
  • Legacy Wealth Asset Management first reported a position in LeMaitre Vascular in Q4 2020 and held it in 22 quarters.
  • Legacy Wealth Asset Management's LeMaitre Vascular position peaked at $915K in Q3 2022.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.